While simplification is becoming a popular buzzword in the pharmaceutical sector these days, the drive for simplicity is certainly not new. In 2008, the U.S. Environmental Protection Agency (EPA) initiated a massive study to streamline its own lab costs and increase productivity. The title of the EPA’s final report pretty much said it all: Commonsense Actions and Best Practices That Improve Laboratory Efficiency and Effectiveness. Among the study’s many observations were two important findings applicable to the entire research industry. To become more efficient and effective, labs need to initiate a deep-dive analysis into everything they do. Based on those findings, lab directors need to then put things that add value to the efficiencies and effectiveness of the lab into one bucket and relegate everything else to another bucket – preferably for someone else to do. In fact, the EPA found that its highest cost savings were when contractors operated in government-owned laboratories working side-by-side with its own scientists in providing those same non-value-added tasks and services.
Download the Full White Paper